Showing 631-640 of 1377 results for "".
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- IL-17 Linked to Skin Aging: Studyhttps://modernaesthetics.com/news/il-17-linked-to-skin-aging-study/2473426/Interleukin (IL)-17 may plays a central role in skin aging, according to research from Institute for Research in Biomedicine (IRB Barcelona) in collaboration with the National Center for Genomic Analysis (CNAG). The study, which was led by Dr. Guiomar Solanas, Dr. Salvador Azn
- Body Contouring Doesn't Increase Long-term Weight Loss after Bariatric Surgery: Studyhttps://modernaesthetics.com/news/body-contouring-doesnt-increase-long-term-weight-loss-after-bariatric-surgery-study/2473421/For patients who experience massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated with long-term weight loss, reports a
- Reveal Lasers Launches Eternahttps://modernaesthetics.com/news/reveal-lasers-launches-eterna-topic/2473419/Reveal Lasers LLC is launching Eterna, a radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables. "We are thrilled to introduce Eterna to the market," says Bob Daley, CEO of Reveal Lasers, in a
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- FDA Clears Renuvion APR Handpiece for Coagulation of Subcutaneous Soft Tissues after Liposuction for Body Contouringhttps://modernaesthetics.com/news/fda-clears-renuvion-apr-handpiece-for-coagulation-of-subcutaneous-soft-tissues-after-liposuction-for-body-contouring/2473404/The U.S. Food and Drug Administration (FDA) cleared the Renuvion APR Handpiece for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring. “The Renuvion APR handpiece is the only device to have a 510(k)
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).
- Allergan Aesthetics Supports Women Surgeons with LIMITLESShttps://modernaesthetics.com/news/allergan-aesthetics-supports-women-surgeons-with-limitless/2473394/Allergan Aesthetics is launching LIMITLESS, an ongoing initiative in partnership with American Society of Plastic Surgeons (ASPS), The Aesthetic Society and the American Hernia Society. LIMITLESS was developed three years ago as a program to highlight women's achievements in p
- Ali Wentworth, Laura Geller Beauty Release New Film for Annual National Mature Women's Day Campaignhttps://modernaesthetics.com/news/ali-wentworth-laura-geller-beauty-for-annual-national-mature-womens-day-campaign/2473387/Laura Geller Beauty is unveiling "The Invisible Woman,” a new film created in partnership with actress, author, and producer Ali Wentworth for their 2023 campaign for National Mature Women's Day. The film showcases Wentworth at a crowded bar as she describes the univ
- Establishment Labs Surpasses 3 Million Motiva Deviceshttps://modernaesthetics.com/news/establishment-labs-surpasses-3-million-motiva-devices/2473383/Establishment Labs Holdings announced that it has surpassed 3 million Motiva devices in market. The devices have been delivered to plastic and reconstructive surgeons since 2010 and are available in more than 85 countries. “Since its founding, Establishment Labs has been guid